Myosin Inhibitor Cell Induction Method
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for transdifferentiating fibroblasts into adipocytes, immortalizing cells, and amplifying hepatocytes are inefficient and pose safety concerns due to the use of macromolecular substances and transgenic operations, with limited applicability and high risk of genetic engineering-related issues.
Innovation Solution
The use of Myosin inhibitors such as (−)-Blebbistatin and its derivative (S)-(−)-Blebbistatin O-Benzoate, which are cell-permeable and do not interfere with mitosis or contractile ring assembly, are employed to induce transdifferentiation, immortalization, and amplification of fibroblasts and hepatocytes in a single-factor, single-treatment process, utilizing specific media compositions to achieve efficient and safe cell transformation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If macromolecular substances and transgenic operations are used for cell transdifferentiation and immortalization, then the transformation can be achieved, but the safety is compromised and the efficiency is low
Solution Approach 1:
The invention changes the chemical parameters of the induction medium by incorporating specific small molecule compounds (SB431542, GSK126, E61541, tranylcypromine, and forskolin) with defined concentrations and molecular weights. This parameter change enables efficient transdifferentiation without macromolecular substances or transgenic operations, simultaneously improving both safety and efficiency
Solution Approach 2:
The invention substitutes the mechanical/biological system of transgenic operations and macromolecular substance delivery with a chemical system using small molecule compounds. This substitution eliminates the safety concerns associated with genetic engineering while maintaining or improving transdifferentiation efficiency through direct chemical modulation of cellular pathways
2Productivity
If multiple cytokines and growth factors are used for fibroblast to adipocyte transdifferentiation, then the transdifferentiation can be induced, but the process complexity increases and efficiency decreases
Solution Approach 1:
The invention merges multiple signaling pathway modulations into a single integrated induction medium formulation containing five specific small molecule compounds. This combination approach simplifies the overall process by replacing multiple separate cytokine treatments with one unified medium composition, reducing operational complexity while enhancing transdifferentiation efficiency
Solution Approach 2:
The invention creates a composite chemical formulation in the induction medium that combines five different small molecule compounds with complementary mechanisms of action. This composite material approach enables synergistic effects that improve transdifferentiation efficiency while maintaining process simplicity through a single medium application
3Duration of action of moving object
If traditional cell culture methods are used, then cells can be maintained, but the proliferation is limited and senescence occurs after a certain number of passages
Solution Approach 1:
The invention applies preliminary chemical treatment with small molecule compounds to cells before they reach senescence. This preliminary action modifies cellular pathways in advance to prevent senescence onset, enabling long-term proliferation while maintaining cell functionality and avoiding the limitations of traditional culture methods
Data Source
AI summary
The present invention relates to a cell induction method, in particular to a method for inducing differentiation of fibroblasts into adipocytes, comprising the following steps: Cultivating the fibroblasts in a culture medium, adding a Myosin inhibitor and BMP4 to the culture medium, and continuously cultivating same until adipocytes are obtained. The present invention further relates to a method for inducing the conversion of fibroblasts into immortalized cells and use thereof. The method comprises the following steps: cultivating the fibroblasts in a culture medium, adding Myosin inhibitor to the culture medium, and continuously cultivating same until immortalized cells are obtained. The present invention further relates to a method for inducing in vitro amplification of hepatocytes. The present invention further relates to use of a Myosin inhibitor, especially (−)-Blebbistatin or (S)-(−)-Blebbistatin, O-Benzoate, and hepatocytes obtained by means of the method for inducing in vitro amplification of hepatocytes, constructing of bioartificial livers, and constructing models of liver disease.